FL
FLMNY.US Fielmann Aktiengesellschaft
- Market cap
- USD 4.00B
- P/E
- 15.9x
- P/B
- 3.26x
- ROE
- 20.3%
- Dividend yield
- 3.35%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is FLMNY.US undervalued?
Graham numberFLMNY.US trades 51.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fielmann Aktiengesellschaft fundamental analysis
No fundamental analysis for Fielmann Aktiengesellschaft yet.
Fielmann Aktiengesellschaft stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fielmann Aktiengesellschaft
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, ready-made reading glasses, hearing systems and its accessories, as well as personal protective equipment. It also offers its products under the fielmann, Optika Clarus, Optica & Audiologia Universitaria, Medical optica …
Full company profileFielmann Aktiengesellschaft financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Fielmann Aktiengesellschaft annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.34B | 1.39B | 1.43B | 1.52B | 1.43B | 1.68B | 1.76B | 1.97B | 2.26B | 2.34B | 2.53B |
| Gross Profit | 1.06B | 1.11B | 1.14B | 1.22B | 1.15B | 1.34B | 1.38B | 1.57B | 1.81B | 630M | 2.03B |
| Operating Income | 240M | 254M | 250M | 257M | 339M | 219M | 235M | 287M | 342M | 311M | 563M |
| EBITDA | 282M | 293M | 297M | 386M | 331M | 397M | 347M | 414M | 476M | 532M | 533M |
| Net Income | 166M | 168M | 169M | 172M | 116M | 137M | 104M | 128M | 152M | 196M | 226M |
| EPS | 0.40 | 0.40 | 0.40 | 0.41 | 0.28 | 0.33 | 0.25 | 0.30 | 0.36 | 0.47 | 0.54 |
| Balance Sheet | |||||||||||
| Total Assets | 914M | 926M | 945M | 1.37B | 1.67B | 1.74B | 1.77B | 1.99B | 2.37B | 2.66B | - |
| Total Liabilities | 227M | 231M | 236M | 640M | 833M | 863M | 913M | 1.06B | 1.46B | 1.67B | -1.11B |
| Shareholders' Equity | 686M | 695M | 709M | 723M | 779M | 820M | 804M | 792M | 899M | 981M | 1.11B |
| Cash & Short-term Investments | 280M | 290M | 248M | 237M | 221M | 236M | 150M | 81.8M | 102M | 227M | 269M |
| Total Debt | 1.48M | 1.71M | 822K | 373M | 426M | 458M | 506M | 592M | 874M | 884M | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 219M | 287M | 193M | 302M | 278M | 347M | 245M | 283M | 410M | 446M | - |
| Capital Expenditure | 48.7M | 66.2M | 76.0M | 100M | 90.1M | 86.5M | 85.4M | 86.8M | 82.7M | 108M | 0.00 |
| Free Cash Flow | 170M | 221M | 117M | 202M | 188M | 260M | 160M | 196M | 327M | 338M | - |
| Ratios | |||||||||||
| ROE | 24.2% | 24.1% | 23.8% | 23.8% | 14.9% | 16.7% | 12.9% | 16.1% | 16.9% | 19.9% | 20.3% |
| ROA | 18.2% | 18.1% | 17.9% | 12.6% | 7.0% | 7.9% | 5.9% | 6.4% | 6.4% | 7.3% | - |
| Net Profit Margin | 12.4% | 12.1% | 11.8% | 11.3% | 8.1% | 8.2% | 5.9% | 6.5% | 6.7% | 8.4% | 8.9% |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.52x | 0.55x | 0.56x | 0.63x | 0.75x | 0.97x | 0.90x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Fielmann Aktiengesellschaft dividends
- Dividend yield
- 3.35%
- Forward dividend
- 0.32 USD
- Payout ratio
- 47.4%
- Ex-dividend date
- Jul 13, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 92.7M | 0.22 | 47.4% |
| 2024 | EUR 84.0M | 0.20 | 55.2% |
| 2023 | EUR 63.0M | 0.15 | 49.3% |
| 2022 | USD 126M | 0.30 | 121.5% |
| 2021 | USD 101M | 0.24 | 73.6% |
| 2020 | USD 91.1M | 0.22 | 78.3% |
| 2019 | USD 160M | 0.38 | 92.6% |
| 2018 | EUR 160M | 0.38 | 94.8% |
| 2017 | EUR 156M | 0.37 | 93.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Fielmann Aktiengesellschaft
Ownership data of Fielmann Aktiengesellschaft is not available yet.
Fielmann Aktiengesellschaft company profile
- Company name
- Fielmann Aktiengesellschaft
- Ticker
- FLMNY.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 18,213
- Fiscal year end
- December
- Address
- Fuhlsbuettler Strasse 399, Hamburg, Germany, 22309
- Phone
- 49 40 27076 0
- Website
- fielmann-group.com
About Fielmann Aktiengesellschaft
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, ready-made reading glasses, hearing systems and its accessories, as well as personal protective equipment. It also offers its products under the fielmann, Optika Clarus, Optica & Audiologia Universitaria, Medical optica audicion, Shopko Optical, and SVS VISION brand names. The company sells its products through digital sales, retail stores, as well as Befitting, an optical e-commerce platform. The company was formerly known as Fielmann Aktiengesellschaft and changed its name to Fielmann Group AG in July 2023. Fielmann Group AG was founded in 1972 and is headquartered in Hamburg, Germany. Fielmann Group AG operates as a subsidiary of Korva SE.
Fielmann Aktiengesellschaft management
6- Mr. Marc FielmannChairman of the Mgmt Board, CEO, Head of Strategy, Category Management & Purchasing · born 1989
- Dr. Bastian Koerber Ph.D.Chief Sales Officer, Marketing, Expansion, Real Estate & Member of the Management Board · born 1975
- Mr. Steffen BaetjerCFO, Head of Finance, Controlling, Legal and Compliance & Member of Management Board · born 1969
- Ms. Katja GrossCHRO, Head of Digital and IT & Member of Management Board · born 1976
- Mr. Peter S. LothesCOO, Head of Manufacturing and Logistics & Member of Management Board · born 1966
- Nils ScharwaechterDirector of Investor Relations